Medical Amino Acid Market Report 2026

Medical Amino Acid Market Overview

• Medical Amino Acid market size has reached to $4.11 billion in 2025 • Expected to grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Rising Liver Disease Incidence Fueling The Growth Of The Market Due To Increasing Need For Nutritional Liver Support • Market Trend: Next-Generation Multi-Chamber Formulations For Clinical Nutrition • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Medical Amino Acid Market?

Medical amino acids are specially formulated amino acids designed to support specific physiological needs, particularly in individuals with metabolic or health-related conditions that affect protein digestion or amino acid absorption. These amino acids are synthesized to provide precise nutritional content, ensuring balanced intake of essential and non-essential amino acids required for the body's growth, repair, and maintenance functions. The main product types of medical amino acids are L-glutamine, L-arginine, L-lysine, L-leucine, L-isoleucine, L-valine, and others. L-glutamine is a conditionally essential amino acid, meaning the body typically produces enough, but during periods of illness, injury, or stress, supplementation becomes necessary. It is applied for medical supplements, medicinal foods, active pharmaceutical ingredients (API), pharmaceutical intermediates, and cell culture ingredients and used by several end-users, including hospitals, research laboratories, clinics, pharmaceutical companies, and nutraceutical companies.

What Is The Medical Amino Acid Market Growth Forecast?

The medical amino acid market size is expected to see strong growth in the next few years. It will grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to advancements in medical amino acid synthesis, rising demand for personalized nutrition, expansion of clinical and hospital applications, growing pharmaceutical and cell culture research, development of novel delivery methods for amino acids. Major trends in the forecast period include rising demand for amino acid-based medical nutrition, growth in specialized supplements for metabolic disorders, increased adoption of injectable amino acid formulations, expansion of amino acids in pharmaceutical intermediates, focus on high-purity and clinical-grade amino acid products.

Global Medical Amino Acid Market Segmentation

1) By Product Type: L-Glutamine, L-Arginine, L-Lysine, L-Leucine, L-Isoleucine, L-Valine, Other Product Types 2) By Application: Medical Supplements, Medicinal Foods, Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, Cell Culture Ingredients 3) By End-User: Hospitals, Research Laboratories, Clinics, Pharmaceutical Companies, Nutraceutical Companies Subsegments: 1) By L-Glutamine: Powder Form, Capsule Form, Injectable Form 2) By L-Arginine: Oral Solution, Tablets, Intravenous Injection 3) By L-Lysine: Hydrochloride Form, Acetate Form, Supplement Blends 4) By L-Leucine: Branched-Chain Form, Micronized Powder, Pharmaceutical Grade 5) By L-Isoleucine: Isolated Form, Blended BCAA Form, Medical Nutrition Formulas 6) By L-Valine: Standalone Supplement, BCAA Combination, Clinical Nutrition Use 7) By Other Product Types: L-Tryptophan, L-Carnitine, L-Threonine, L-Histidine, Specialty Amino Acids

What Is The Driver Of The Medical Amino Acid Market?

The rising incidence of liver diseases is expected to propel the growth of the medical amino acid market going forward. Liver disease is a broad term for disorders that negatively affect the liver's structure or function, disrupting its essential roles in the body. Liver diseases are rising due to increasing rates of obesity, which contribute to the development of non-alcoholic fatty liver disease as excess fat accumulates in liver cells and impairs their function. Medical amino acids manage liver-related metabolic imbalances and support liver cell regeneration, making them essential in nutritional therapy for affected patients. For instance, in September 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, chronic liver disease and cirrhosis caused 52,222 deaths in the United States in 2023, making it the ninth leading cause of death. Therefore, the rising incidence of liver diseases drives the medical amino acid industry.

Key Players In The Global Medical Amino Acid Market

Major companies operating in the medical amino acid market are Evonik Industries AG, Ajinomoto Co. Inc., Nippon Kayaku Co. Ltd., FUJIFILM Irvine Scientific, Kyowa Hakko Bio Co. Ltd., Aelicure Pharma, Shanghai Kyowa Amino Acid Co. Ltd.

Global Medical Amino Acid Market Trends and Insights

Major companies operating in the medical amino acid market are focusing on developing innovative formulations, such as high-calorie parenteral nutrition injections, to improve patient nutrition and support recovery in those unable to eat orally. High-calorie parenteral nutrition injections are nutrient-rich solutions delivered intravenously, containing amino acids, glucose, electrolytes, and vitamins, which help support energy needs, protein synthesis, and recovery in patients who cannot eat or absorb nutrients normally. For instance, in November 2024, Otsuka Pharmaceutical Factory Inc., a Japan‑based pharmaceutical and nutrition company, launched KIDPAREN Injection, a kit formulation for high‑calorie parenteral nutrition tailored to CKD patients. The product is composed of a 1,050 mL three‑chamber bag combining amino acids, glucose, electrolytes (excluding potassium and phosphorus) and multivitamins; it provides approximately 1,500 kcal in a fluid‑restricted volume and allows easy aseptic mixing by breaking the centre seal before infusion. Unlike traditional parenteral nutrition, which often involves separate preparation of amino acid solutions, TPN bases, vitamins and electrolytes, increasing preparation time and risk of compounding errors this kit simplifies administration, reduces burden on healthcare settings and is optimised for patients who cannot tolerate standard feeding.

What Are Latest Mergers And Acquisitions In The Medical Amino Acid Market?

In October 2023, Grand Pharmaceutical Group Limited, a Hong Kong-based pharmaceutical company, acquired Hubei Bafeng for $37.24 million (RMB 270 million). With this acquisition, Grand Pharmaceutical Group aimed to enhance its production capacity and diversify its portfolio by integrating Hubei Bafeng’s expertise in amino acid APIs and clinical nutrition products. Hubei Bafeng is a China-based provider of medical amino acids.

Regional Insights

North America was the largest region in the medical amino acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Medical Amino Acid Market?

The medical amino acid market consists of sales of amino acid blends, protein-free medical formulas, amino acid powders, and amino acid-based drinks. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Medical Amino Acid Market Report 2026?

The medical amino acid market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical amino acid industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.